Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model

Erin G Reed-Geaghan1, Andrew L Croxford2, Burkhard Becher2

  • 1Department of Neurosciences, School of Medicine, Case Western Reserve University, Cleveland, OH.

Insights

Alzheimer's disease involves brain inflammation from myeloid cells. This study proves these cells originate solely from resident microglia, not circulating monocytes, offering therapeutic insights.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Alzheimer's disease (AD) features brain inflammation driven by myeloid cells near amyloid plaques.
  • These plaque-associated myeloid cells display altered gene expression and protect against neuritic dystrophy.
  • The cellular origin of these myeloid cells in AD is critical for developing targeted therapies.

Purpose of the Study:

  • To definitively determine the origin of myeloid cells associated with amyloid plaques in the Alzheimer's disease brain.
  • To investigate whether circulating peripheral monocytes contribute to the myeloid cell population at plaque sites.

Main Methods:

  • Utilized genetic labeling techniques to trace the lineage of myeloid cell populations within the brain.
  • Distinguished between resident microglia and infiltrating peripheral monocytes in an Alzheimer's disease model.

Main Results:

  • Unequivocally demonstrated that all plaque-associated myeloid cells in the AD brain are derived from resident microglia.
  • Confirmed a complete absence of contribution from circulating peripheral monocytes to these plaque-associated myeloid cells.

Conclusions:

  • Resident microglia are the exclusive source of myeloid cells at amyloid plaques in Alzheimer's disease.
  • This finding clarifies a long-standing controversy and has significant implications for AD-targeted immunotherapies.

Related Concept Videos